Source: Clinical Lab Products

Biotheranostics: Hologic Completes Acquisition of Biotheranostics

Biotheranostics develops and markets two highly differentiated molecular diagnostic tests for breast and metastatic cancers: Breast Cancer Index and CancerType ID.

Read full article »
Est. Annual Revenue
$25-100M
Agree?
Est. Employees
100-250
Agree?
Kevin R. Thornal's photo - Interim-CEO of Biotheranostics

Interim-CEO

Kevin R. Thornal

CEO Approval Rating

82/100

Read more